Ro KhannaBuy
MRNA Common Stock · Transaction Jun 30, 2026 · Filed Jul 6, 2026 · $1,001 to $15,000
XNAS · MRNA
-2.98% · -$4.50 · Vol 1.4M
Live · updated 09:37:17 ET
Moderna, Inc. Common Stock
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
$146.31
Veridion Score
BETALOW CONF · 6 of 6 factors measuredWed Sep 2 · last completed session · daily score · 16h old · MRNA
MethodologyMRNA
Moderna, Inc. Common Stock
Wed Sep 2 · last completed session · daily score · 16h old
Middle range
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
59/ 100
Veridion Score
Middle range · LOW confidence
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 6 of 6 factors measured · Wed Sep 2 · last completed session · daily score · 16h old
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is MRNA moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Moderna, Inc. Common Stock
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)Founded
2010
Listed
2018
Employees
5K
Country
US
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 25 mRNA development candidates in clinical studies as of March 2026. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$145.94
Day high
$150.20
Day low
$144.30
Previous close
$150.81
52W high
$174.38
-16.09% from high
52W low
$22.36
82% of range
Market cap
$60.2B
EPS
$-8.0100
Beta
2.14
Shares out
399.2M
Volume
1.4M
0.06× rel vol
Avg volume
23.5M
VWAP
$146.51
Price history computed in-house
1W
+2.48%
1M
+156.74%
3M
+208.42%
1Y
+508.38%
YTD
+396.15%
SMA 50 $82.01 · above
SMA 200 $53.60 · above
52W position 82%
MRNA overview
Related filings and maps
Public disclosures
Congress activity in MRNA
Official filing ↗
Ro KhannaSell
MRNA Common Stock · Transaction May 15, 2026 · Filed Jun 9, 2026 · $1,001 to $15,000
Ro KhannaSell
MRNA Common Stock · Transaction May 1, 2026 · Filed Jun 9, 2026 · $1,001 to $15,000
Ro KhannaBuy
MRNA Common Stock · Transaction Apr 13, 2026 · Filed May 11, 2026 · $1,001 to $15,000
Ro KhannaBuy
MRNA Common Stock · Transaction Jan 23, 2026 · Filed Feb 6, 2026 · Amount pending receipt enrichment
Federal contracts
MRNA contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for MRNA in this window.
Lobbying spend
MRNA lobbying filings, year to date.
Registered lobbying filings matched to Moderna, Inc. Common Stock.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for MRNA in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for MRNA.
Options
Sovereign unlock shows live options positioning for MRNA.